Albert Seymour
2017
In 2017, Albert Seymour earned a total compensation of $756.2K as Chief Scientific Officer at Homology Medicines.
Compensation breakdown
| Non-Equity Incentive Plan | $126,175 |
|---|---|
| Option Awards | $269,545 |
| Salary | $360,500 |
| Total | $756,220 |
Seymour received $360.5K in salary, accounting for 48% of the total pay in 2017.
Seymour also received $126.2K in non-equity incentive plan and $269.5K in option awards.
Rankings
In 2017, Albert Seymour's compensation ranked 10,263rd out of 14,666 executives tracked by ExecPay. In other words, Seymour earned more than 30.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,263 out of 14,666 | 30th |
Division Manufacturing | 3,979 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,400 out of 2,075 | 33rd |
Industry group Drugs | 1,138 out of 1,731 | 34th |
Industry Pharmaceutical Preparations | 888 out of 1,333 | 33rd |
Source: SEC filing on April 25, 2019.
Seymour's colleagues
We found one more compensation record of an executive who worked with Albert Seymour at Homology Medicines in 2017.
2017
Arthur Tzianabos
Homology Medicines